Cargando…
Salient features of mesenchymal stem cells—implications for Ewing sarcoma modeling
Despite a heightened appreciation of the many defining molecular aberrations in Ewing sarcoma, the cooperative genetic environment and permissive cell of origin essential for EWS/ETS-mediated oncogenesis remain elusive. Consequently, inducible animal and in vitro models of Ewing sarcoma from a nativ...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580960/ https://www.ncbi.nlm.nih.gov/pubmed/23443465 http://dx.doi.org/10.3389/fonc.2013.00024 |
_version_ | 1782260352588709888 |
---|---|
author | Monument, Michael J. Bernthal, Nicholas M. Randall, R. Lor |
author_facet | Monument, Michael J. Bernthal, Nicholas M. Randall, R. Lor |
author_sort | Monument, Michael J. |
collection | PubMed |
description | Despite a heightened appreciation of the many defining molecular aberrations in Ewing sarcoma, the cooperative genetic environment and permissive cell of origin essential for EWS/ETS-mediated oncogenesis remain elusive. Consequently, inducible animal and in vitro models of Ewing sarcoma from a native cellular context are unable to fully recapitulate malignant transformation. Despite these shortcomings, human, and murine mesenchymal stem cells (MSCs) are the closest working in vitro systems available. MSCs are tolerant of ectopic EWS/FLI expression, which is accompanied by a molecular signature most similar to Ewing sarcoma. Whether MSCs are the elusive cell of origin or simply a tolerant platform of the EWS/FLI transcriptome, these cells have become an excellent molecular tool to investigate and manipulate oncogenesis in Ewing sarcoma. Our understanding of the biological complexity and heterogeneity of human MSCs (hMSCs) has increased substantially over time and as such, appreciation and utilization of these salient complexities may greatly enhance the efficient use of these cells as surrogate models for Ewing sarcoma tumorigenesis. |
format | Online Article Text |
id | pubmed-3580960 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-35809602013-02-26 Salient features of mesenchymal stem cells—implications for Ewing sarcoma modeling Monument, Michael J. Bernthal, Nicholas M. Randall, R. Lor Front Oncol Oncology Despite a heightened appreciation of the many defining molecular aberrations in Ewing sarcoma, the cooperative genetic environment and permissive cell of origin essential for EWS/ETS-mediated oncogenesis remain elusive. Consequently, inducible animal and in vitro models of Ewing sarcoma from a native cellular context are unable to fully recapitulate malignant transformation. Despite these shortcomings, human, and murine mesenchymal stem cells (MSCs) are the closest working in vitro systems available. MSCs are tolerant of ectopic EWS/FLI expression, which is accompanied by a molecular signature most similar to Ewing sarcoma. Whether MSCs are the elusive cell of origin or simply a tolerant platform of the EWS/FLI transcriptome, these cells have become an excellent molecular tool to investigate and manipulate oncogenesis in Ewing sarcoma. Our understanding of the biological complexity and heterogeneity of human MSCs (hMSCs) has increased substantially over time and as such, appreciation and utilization of these salient complexities may greatly enhance the efficient use of these cells as surrogate models for Ewing sarcoma tumorigenesis. Frontiers Media S.A. 2013-02-25 /pmc/articles/PMC3580960/ /pubmed/23443465 http://dx.doi.org/10.3389/fonc.2013.00024 Text en Copyright © 2013 Monument, Bernthal and Randall. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc. |
spellingShingle | Oncology Monument, Michael J. Bernthal, Nicholas M. Randall, R. Lor Salient features of mesenchymal stem cells—implications for Ewing sarcoma modeling |
title | Salient features of mesenchymal stem cells—implications for Ewing sarcoma modeling |
title_full | Salient features of mesenchymal stem cells—implications for Ewing sarcoma modeling |
title_fullStr | Salient features of mesenchymal stem cells—implications for Ewing sarcoma modeling |
title_full_unstemmed | Salient features of mesenchymal stem cells—implications for Ewing sarcoma modeling |
title_short | Salient features of mesenchymal stem cells—implications for Ewing sarcoma modeling |
title_sort | salient features of mesenchymal stem cells—implications for ewing sarcoma modeling |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580960/ https://www.ncbi.nlm.nih.gov/pubmed/23443465 http://dx.doi.org/10.3389/fonc.2013.00024 |
work_keys_str_mv | AT monumentmichaelj salientfeaturesofmesenchymalstemcellsimplicationsforewingsarcomamodeling AT bernthalnicholasm salientfeaturesofmesenchymalstemcellsimplicationsforewingsarcomamodeling AT randallrlor salientfeaturesofmesenchymalstemcellsimplicationsforewingsarcomamodeling |